Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline/taxane-based chemotherapy
Campone, M, Cortes-Funes, H, Vorobiof, D, Martin, M, Slabber, C F, Ciruelos, E, Bourbouloux, E, Mendiola, C, Delgado, F M, Colin, CVolume:
95
Year:
2006
Language:
english
Pages:
6
DOI:
10.1038/sj.bjc.6603347
File:
PDF, 107 KB
english, 2006